Analyst Ratings January 28, 2026

Mizuho Lowers Qorvo Price Target to $70 Citing Softer Revenue Guidance

Analysts note strong margins but trim fiscal 2027 revenue view as mobile pressures and segment weakness weigh on outlook

By Derek Hwang QRVO
Mizuho Lowers Qorvo Price Target to $70 Citing Softer Revenue Guidance
QRVO

Mizuho cut its price target on Qorvo Inc. to $70 from $85 while keeping a Neutral rating after the company issued revenue guidance below expectations. Qorvo reported a December-quarter revenue of $993 million and EPS of $2.17, but guided March-quarter revenue to $800 million, below consensus. The company trimmed fiscal 2027 revenue by roughly $300 million, forecasting mid-single-digit year-over-year declines, even as it expects gross margins above 50% and EPS near $7.

Key Points

  • Mizuho cut its Qorvo price target to $70 from $85 and kept a Neutral rating amid weaker revenue guidance.
  • Qorvo reported December-quarter revenue of $993 million and EPS of $2.17, but guided March-quarter revenue to $800 million, below consensus.
  • Fiscal 2027 revenue was reduced by roughly $300 million while management still expects gross margins above 50% and EPS near $7.

Mizuho has reduced its price objective for Qorvo Inc. to $70 from $85 while retaining a Neutral rating, pointing to a revenue outlook that came in weaker than market expectations. Analyst targets for the company now span from $70 to $128, and a Fair Value assessment included in analyst data indicates the shares may be undervalued.

Qorvo reported December-quarter revenue of $993 million and earnings per share of $2.17, results that were in line with expectations. However, the company guided fiscal third-quarter (March quarter) revenue down about 19% sequentially to $800 million, beneath the consensus estimate of $904 million.

Management also lowered its fiscal 2027 revenue forecast by approximately $300 million. That reduction translates to a mid-single-digit percentage decline year-over-year versus consensus expectations of flat to positive growth. Despite the revenue trimming, Qorvo projected gross margins above 50% for fiscal 2027 and an earnings-per-share figure of about $7.

On margins, the company reported a December-quarter gross margin of 49.1%, down 60 basis points from the prior quarter but slightly ahead of the 48% consensus. For the March quarter, Qorvo guided to another 60 basis point decline in gross margin, a level that remains above the consensus estimate of 46.6%.

Balance-sheet metrics presented in the report indicate a moderate leverage profile, with total debt to capital at 0.17, and a healthy liquidity position, reflected in a current ratio of 3.67. Analyst data included in the coverage assigns Qorvo an overall financial health score of "GOOD."

Mizuho's fiscal 2027 segmentation outlook shows divergent trends across product groups. The high-performance analog (HPA) business is expected to deliver double-digit percentage growth, the connectivity and sensors group (CSG) is forecast to be flat year-over-year, and the advanced cellular group (ACG) is anticipated to decline compared with the prior year. Revenue from Apple is projected to remain approximately flat year-over-year under this outlook.

Additional analyst moves coincided with the company's reported results. Morgan Stanley trimmed its price target for Qorvo to $84.00 from $110.00 while maintaining an Equalweight rating. That adjustment was attributed to pressures within Qorvo's mobile business, including share losses in upcoming iPhone models and a faster-than-expected exit from lower-tier Android devices. Following the earnings release, Qorvo's shares rose about 0.61% in after-market trading.

The combination of in-line quarterly results, softer forward revenue guidance and persistent mobile-market headwinds produced a nuanced picture: solid profitability metrics and liquidity on one hand, and a reduced revenue trajectory and segment-specific weaknesses on the other. Market participants and sector observers will likely continue to dissect segment performance and customer dynamics as indicators of the durability of the firm's recovery and the sustainability of margins.


Summary of key metrics and guidance:

  • December-quarter revenue: $993 million
  • December-quarter EPS: $2.17
  • March-quarter revenue guidance: $800 million (down ~19% quarter-over-quarter; consensus $904 million)
  • Fiscal 2027 revenue trimmed by ~ $300 million (mid-single-digit % decline year-over-year vs. consensus flat to positive)
  • Fiscal 2027 gross margin guidance: above 50%; EPS guidance: ~ $7
  • December-quarter gross margin: 49.1% (down 60 bps quarter-over-quarter; consensus 48%)
  • March-quarter gross margin guidance: down another 60 bps, still above the 46.6% consensus
  • Balance sheet: total debt to capital 0.17; current ratio 3.67; overall financial health score noted as "GOOD"

The near-term outlook centers on demand and share dynamics in mobile end markets and the ability of higher-margin product lines to offset declines elsewhere. Investors and industry participants should monitor quarterly revenue execution, segment trends for HPA, CSG and ACG, and any updates on customer mix and content with major smartphone partners.

Risks

  • Revenue guidance fell short of consensus, creating uncertainty for semiconductor and mobile supply-chain demand - this impacts semiconductor suppliers and smartphone OEMs.
  • Pressure in Qorvo's mobile business and reported share loss in upcoming iPhone models, along with a faster exit from lower-tier Android devices, pose execution risk for mobile-related revenue.
  • Declines forecast in the advanced cellular group (ACG) and flat performance in connectivity and sensors group (CSG) introduce segment-specific downside risk to overall company growth projections.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026